S2. Addressing ADME Challenges
Session Chair: Max Cummings, Johnson & Johnson
Monday, 09 February 2015, from 14:00 to 17:00
Showcase the use of structure based drug design in overcoming ADME-related challenges in drug discovery, foster discussion of any areas of perceived low-hanging fruit for the application of SBDD to ADME issues.